Targeting HER-2 over expressed breast cancer cells with 2-cyclohexyl-N-[(Z)-(substituted phenyl/furan-2-yl/thiophene-2-yl)methylidene]hydrazinecarbothioamide

被引:15
作者
Bhat, Mashooq Ahmad [1 ]
Al-Dhfyan, Abdullah [2 ,3 ]
Khan, Azmat Ali [1 ]
Al-Harbi, Nouf [2 ]
Manogaran, P. S. [2 ]
Alanazi, Amer M. [1 ]
Fun, Hoong-Kun [1 ,4 ]
Al-Omar, Mohamed A. [1 ]
机构
[1] King Saud Univ, Dept Pharmaceut Chem, Coll Pharm, Riyadh 11451, Saudi Arabia
[2] King Faisal Specialized Hosp & Res Ctr, Stem Cell & Tissue Re Engn Program, Res Ctr, Riyadh 11211, Saudi Arabia
[3] King Saud Univ, Dept Pharmacol & Toxicol, Coll Pharm, Riyadh 11451, Saudi Arabia
[4] Univ Sains Malaysia, Sch Phys, X Ray Crystallog Unit, Usm Penang 11800, Malaysia
关键词
Thiosemicarbazones; Antitumor activity; Breast cancer; HER-2; (2Z)-N-CYCLOHEXYL-2-(3-HYDROXYBENZYLIDINE) HYDRAZINE CARBOTHIOAMIDE; STEM-CELLS; 338.15; K; RESISTANCE; LINES; THIOSEMICARBAZONES; IDENTIFICATION; CHEMOTHERAPY; SOLUBILITY; INHIBITORS;
D O I
10.1016/j.bmcl.2014.11.009
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Cyclohexyl thiosemicarbazone derivatives (C1-14) were synthesized, characterized and evaluated against HER-2 over expressed breast cancer cells. The synthesized compounds were screened in vitro against four breast cancer cell lines; SKBr-3, MCF-7, MDA-MB-468 and MDA-MB-231. All the compounds showed activity against HER-2 over expressed SKBr-3 cells with (IC50 = 25.6 +/- 0.07 mu M-61.6 +/- 0.4 mu M). The most active compounds inhibit ALDH(+) breast cancer stem cells more effectively than the cancer stem cells specific agent Salinomycin. Immunohistochemistry staining also confirmed that these compounds inhibit the expression of HER-2 on SKBr-3 cells. Compound C2 significantly inhibited the cell migration and cell adhesion of breast cancer cell lines. Compound C2 was found to most active compound of this series targeting HER-2 over expressed breast cancer cells. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:83 / 87
页数:5
相关论文
共 24 条
[21]   HUMAN-BREAST CANCER - CORRELATION OF RELAPSE AND SURVIVAL WITH AMPLIFICATION OF THE HER-2 NEU ONCOGENE [J].
SLAMON, DJ ;
CLARK, GM ;
WONG, SG ;
LEVIN, WJ ;
ULLRICH, A ;
MCGUIRE, WL .
SCIENCE, 1987, 235 (4785) :177-182
[22]   Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers [J].
Tanei, Tomonori ;
Morimoto, Koji ;
Shimazu, Kenzo ;
Kim, Seung Jin ;
Tanji, Yoshio ;
Taguchi, Tetsuya ;
Tamaki, Yasuhiro ;
Noguchi, Shinzaburo .
CLINICAL CANCER RESEARCH, 2009, 15 (12) :4234-4241
[23]   Discovery of N-(2,6-dimethylphenyl)-substituted semicarbazones as anticonvulsants:: Hybrid pharmacophore-based design [J].
Yogeeswari, P ;
Sriram, D ;
Thirumurugan, R ;
Raghavendran, JV ;
Sudhan, K ;
Pavana, RK ;
Stables, J .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (20) :6202-6211
[24]   Iet-7 regulates self renewal and tumorigenicity of breast cancer cells [J].
Yu, Fengyan ;
Yao, Herui ;
Zhu, Pengcheng ;
Zhang, Xiaoqin ;
Pan, Qiuhui ;
Gong, Chang ;
Huang, Yijun ;
Hu, Xiaoqu ;
Su, Fengxi ;
Lieberman, Judy ;
Song, Erwei .
CELL, 2007, 131 (06) :1109-1123